Abstract
A canine parainfluenza virus type 5 strain was isolated from a lung sample from a diseased dog. The genome sequene of this isolate, named HeN0718, was determined and compared tho those of other previously reported canine parainfluenza viruses. Unlike previously reported viruses, the HeN0718 strain contained several nucleotide mutations in the SH gene that led to a frame shift in the open reading frame. Phylogenetic analysis based on the complete virus genome and the P, F, and HN genes showed that HeN0718 was genetically closest to D277, a Korean strain that was isolated in 2008.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Parainfluenza virus type 5 (PIV5) is a non-segmented negative-strand RNA virus that belongs to the genus Rubulavirus of the family Paramyxoviridae [1]. The family Paramyxoviridae currently contains seven genera including Respirovirus, Rubulavirus, Avulavirus, Morbillivirus, Aquaparamyxovirus, Ferlavirus, and Henipavirus [2]. PIV5 was first isolated in 1956 from primary monkey kidney cells [3]. Since then, PIV5 has been isolated from a wide range of species including humans, pigs, cats, and rodents [4, 5]. It is a natural causative agent of the respiratory illness kennel cough in dogs, and as a consequence, it is often referred to as “canine parainfluenza virus” in the veterinary field [6]. PIV5 is the main infectious cofactor of a canine respiratory disease complex, and the main clinical symptoms of this disease included running nose, fever and cough [7, 8].
PIV5 has a nucleocapsid surrounded by a lipid envelope [9]. The genome of PIV5 is 15,246 nucleotides in length and is composed of seven genes (N, V/P, M, F, SH, HN and L) flanked by a 3’ leader region and a 5’ trailer region. The PIV5 genome encodes eight proteins from seven genes. From the 3’ end, the virus genome encodes the nucleocapsid protein (N), phosphoprotein (P), V protein (V), matrix protein (M), fusion protein (F), small hydrophobic protein (SH), hemagglutinin-neuraminidase protein (HN), and large protein (L) or RNA polymerase [10, 11].
In this study, the novel PIV5 strain HeN0718 was successfully isolated in Vero cells from a lung sample from a diseased dog in Henan province in China. Genome-wide analysis showed that HeN0718 distinguished itself from other PIV5 isolates by several amino acid differences in the SH protein.
Materials and methods
Virus isolation
Lung tissue of the diseased dog was homogenized in Dulbecco’s modified Eagle medium (DMEM, Gibco, USA) and filtered through a 0.22-μm membrane. The filtrates were subsequently used to inoculate Vero cells for 1 h, which were then maintained with DMEM supplemented with 2% fetal bovine serum (Invitrogen, USA) at 37 °C under 5% CO2. The culture supernatants were harvested when a cytopathic effect (CPE) was observed in 80% of the cells and were stored at -80 °C as virus stock until use. To further identify the virus, an indirect immunofluorescence assay (IFA) was carried out using the mouse monoclonal antibody (4B10); (made in-house and stored at National Research Center for Veterinary Medicine) against the PIV5 F protein and rabbit anti-mouse-specific secondary antibodies labeled with FITC fluorescent dye.
RT-PCR, DNA cloning and sequence analysis
To determine the full-length genomic sequence of the above PIV5 isolate, designated PIV5-HeN0718, primers were designed based on published sequences in GenBank (accession no. JQ_743318.1). Thirteen overlapping fragments covering the whole viral genome were amplified using the primers shown in Table 1. Total RNA was extracted from 200 μL of virus-containing culture supernatant using a Viral Nucleic Acid Extraction Kit II (Geneaid, Taiwan, China) according to the manufacturer’s directions. The purified RNA was used as template in a one-step RT-PCR (TransGen Biotech, China). The RT-PCR products were purified using a TIANgel Midi Purification Kit (TIANGEN, China) and cloned into the plasmid vector pEASY-T1 (TransGen Biotech, China) according to the manufacturer’s instructions. After transformation of Trans1-T1 Phage Resistant Chemically Competent Cell (TransGen Biotech, China), 3-5 positive clones were identified by colony PCR and subjected to sequencing. The complete sequences were constructed using the Seqman program in Lasergene (DNASTAR Inc, Madison, USA) and deposited in GenBank under accession number KY114804.
Multiple alignments and phylogenetic analysis
For phylogenetic analysis, 17 complete genome sequences of PIV5 from different species were obtained from GenBank and used in this study (Table 2). Multiple sequence alignments were performed and nucleotide sequence divergence was calculated using MEGA 5.10 software [12]. The neighbor-joining method was used to construct phylogenetic trees from aligned nucleotide sequences.
Results and discussion
Similar to other parainfluenza viruses, Vero cells inoculated with PIV5 HeN0718 showed considerable CPE, with distinct cell fusion and giant cell formation observed after 48 hours postinfection (dpi) (Fig. 1A). As shown in Fig. 1B, IFA revealed strong and specific positive staining in cells infected with HeN0718, but not in mock-infected cells. To determine the complete genome sequence of HeN0718, 13 pairs of primers were used in RT-PCR. RACE experiments were performed to determine the termini of the HeN0718 genome. The genome of HeN0718 is 15,246 nucleotides long and consists of a 55-nt 3’ leader region, a 14,071-nt protein coding region, and a 31-nt 5’ trailer region. All PIVs, including PIV5, have a single-stranded, nonsegmented, negative-sense RNA genome of approximately 15,000 nucleotides (or 15,246 in the case of PIV5) [9]. The genome of HeN0718 contains seven genes in the order 3’-N-V/P-M-F-SH-HN-L-5’. Full-length sequence analysis showed that the genome of HeN0718 is 96.5% identical to that of the prototype PIV5 strain (PIV5-W3A, GenBank accession no. JQ743318.1) at the nucleotide level. Comparison of the deduced amino acid sequences revealed that the predicted N, V/P(V), V/P(P), M, F, SH, HN, and L proteins of HeN0718 exhibited 98.6%, 97.3%, 96.9%, 96.3%, 95.5%, 71.4%, 95.6%, and 98.9% amino acid sequence identity, respectively, to those of the prototype PIV5 strain (Table 3).
The nucleoprotein (N) gene of HeN0718 was 1732 nt in length and shared 96.8% nucleotide sequene identity with PIV5-W3A. Consistent with previous reports, HeN0718 has the conserved motif 323FAAANYPLLYSYAM336 in the central domain, like other PIV5 isolates [13]. The V/P gene of HeN0718 is 1304 nt in length, encoding both the V and P proteins due to a specific RNA editing mechanism that is a common feature of paramyxoviruses. The first open reading frame (ORF) is 669 nt long, encoding the V protein, and the second ORF is 1177 nt long, with the editing process yielding the phosphoprotein [14]. The V protein has a high degree of sequence conservation among PIVs, whereas the P protein is more variable [15]. The phosphoprotein (P protein) in paramyxoviruses plays multiple roles in the virus proliferation cycle. It functions as a polymerase subunit together with L and is involved in assembly, together with NP, during genome replication [16,17,18]. The function of the P protein in PIV5 is not clear and needs to be investigated further.
The matrix (M) gene of HeN0718 is 1370 nt in length, encoding the M protein, which is the most abundant and conserved protein and plays a pivotal role in virion assembly and release. HeN0718 shares 95.5% and 96.3% sequence identity with PIV5-W3A at the nucleotide level and the amino acid level, respectively. The fusion (F) gene of HeN0718 is 1718 nt in length, with a major 1656-nt ORF encoding a 551-aa protein. Sequence identities between the F gene of HeN0718 strain and other reported strains ranged from 95.3% to 99.5% at the nucleotide level and 95.1% to 98.7% at the amino acid level. HeN0718 contained the F7L, C12Y and I502V changes, which were not found in any other isolates. The F protein of paramyxoviruses mediates fusion of viral and cellular membranes for virus entry and it is activated by cleavage of the F0 protein precursor into a disulfide-bonded subunit structure (F2-s-s-F1) [19,20,21]. Since the F protein is the major antigen protein, the above amino acid changes in the HeN0718 F protein have the potential to compromise the efficacy of current PIV5 vaccines.
The SH gene of HeN0718 is encoded by a single ORF with 147 nucleotides. Previous studies showed that the PIV5 SH protein is not present in all paramyxoviruses [2]. A unique feature of PIV5 that distinguishes it from other mammalian PIVs is the presence of a seventh gene, the SH gene, which is located between the fusion (F) and hemagglutinin-neuraminidase (HN) genes [9]. HeN0718 shared only 83.0% and 71.4% sequence identity with PIV5-W3A at the nucleotide level and the amino acid level, respectively. One distinct difference between HeN0718 and other PIV5 isolates is the critical natural nucleotide mutation at position 133 (T133C), which replaces the stop codon of the SH gene and extends the ORF by four more amino acids (Fig. 2A). Therefore, the HeN0718 SH protein is predicted to be four amino acids longer than those of other PIV5 isolates (Fig. 2B). The SH gene of this nonprimate strain showed a high level of T-C substitutions, consistent with an earlier report [26]. Previous studies showed that theSH protein is not essential for virus growth but plays an important role in PIV5 pathogenesis and inhibition of apoptosis induced by tumor necrosis factor alpha (TNF-α) [22,23,24,25]. Therefore, the affects of the mutations in the HeN0718 SH gene on virus pathogenesis and apoptosis merit further investigation.
The hemagglutinin-neuraminidase protein (HN) gene of HeN0718 is 1876 nt long and encodes a protein of 565 amino acids. The HN protein is a type II membrane glycoprotein that has been shown to be important for virus entry and induction of conformational changes in the F protein that are involved in the process of cell membrane fusion [27,28,29]. The conserved N-linked glycan sites at N110, N139, N267, N497 and N504 were also observed in HeN0718. The large polymerase (L) protein of HeN0718 is 6810 nt in length. HeN0718 shares 97.7% and 98.9% sequence identity with PIV5-W3A at the nucleotide level and the amino acid level, respectively. As one of the major components of the RNA polymerase, the L protein has six highly conserved domains that are involved in nucleotide polymerization, mRNA capping and methylation, and viral mRNA polyadenylation [2]. The HeN0718 L protein does not contain any sequence variations within these six conserved domains.
The complete genome sequence of PIV5 HeN0718 was aligned with 17 sequences of PIV5 strains that were isolated from different species, including humans, macaques, dogs, pigs, a calf and a lesser panda. The results showed that PIV5 HeN0718 shared similarities with other viruses, with sequence identity ranging from 95.5% to 99.5% at the nucleotide level and 79.8% to 98.8% at the amino acid level. It is notable that while PIV5 HeN0718 showed 97% sequence identity at the nucleotide level and 92.6% at the amino acid level with a PIV5 strain from a lesser panda (ZJQ-221), which was also isolated in China, the amino acid sequences of the SH genes were only 72% identical, and the HeN0718 SH protein was longer by four amino acids. Phylogenetic trees were constructed based on nucleotide sequence alignments of the complete genome and the P, F, and HN proteins of PIV5-HeN0718 and 16 PIV5 isolates (Fig. 3A-D). Our data showed that HeN0718 was closely related to strain D277, (KC237065.1), a virus isolate from a dog in Korea.
In conclusion, in this study, we report the genome sequence of PIV5 HeN0718, which was isolated from a dog in China. Different from other reported PIV5 isolates, HeN0718 had several nucleotide mutations in the SH gene, resulting in four additional amino acids in the SH protein.
References
Chen Z, Xu P, Salyards GW, Harvey SB, Rada B, Fu ZF, He B (2012) Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5. PloS One 7:e50144–e50144
Lamb RA, Parks GD (2007) Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Fields Virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1449–1496
Hull RN, Minner JR, Smith JW (1956) New viral agents recovered from tissue cultures of monkey kidney cells. I. Origin and properties of cytopathogenic agents S.V.1, S.V.2, S.V.4, S.V.5, S.V.6, S.V.11, S.V.12 and S.V.15. Am J Epidemiol 63:204–215
Chatziandreou N, Stock N, Young D, Andrejeva J, Hagmaier K, Mcgeoch DJ, Randall RE (2004) Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). J Gen Virol 85:3007–3016
Hsiung GD (1972) Parainfluenza-5 virus. Infection of man and animal. Prog Med Virol 14:241–274
Cornwell HJ, Mccandlish IA, Thompson H, Laird HM, Wright NG (1976) Isolation of parainfluenza virus SV5 from dogs with respiratory disease. Vet Rec 98:301–302
Jeoung HY, Song DS, Jeong WS, Lee WH, Song JY, An DJ (2013) Simultaneous detection of canine respiratory disease associated viruses by a multiplex reverse transcription-polymerase chain reaction assay. J Vet Med Sci 75:103–106
Binn LN, Eddy GA, Lazar EC, Helms J, Murnane T (1967) Viruses recovered from laboratory dogs with respiratory disease. Exp Biol Med 126:140–145
Karron RA, Collins PL (2007) Parainfluenza viruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Fields virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1497–1526
Parks GD, Manuse MJ, Johnson JB (2011) The parainfluenza virus simian virus 5. In: Samal SK (ed) The biology of paramyxoviruses. Caister Academic Press, Norfolk, pp 37–68
Tompkins SM, Lin Y, Leser GP, Kramer KA, Haas DL, Howerth EW, Xu J, Kennett MJ, Durbin RK, Durbin JE (2007) Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. Virology 362:139–150
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739
Lee YN, Lee C (2013) Complete genome sequence of a novel porcine parainfluenza virus 5 isolate in Korea. Arch Virol 158:1765–1772
Thomas SM, Lamb RA, Paterson RG (1988) Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54:891–902
Ellis JA, Krakowka GS (2012) A review of canine parainfluenza virus infection in dogs. Javma-J Am Vet Med A 240:273–284
Mary Catherine Bowman SS, Moyer Sue A (1999) Dissection of individual functions of the Sendai virus phosphoprotein in transcription. J Virol 73:6474–6483
Curran J, Pelet T, Kolakofsky D (1994) An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation. Virology 202:875–884
Horikami SM, Curran J, Kolakofsky D, Moyer SA (1992) Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol 66:4901–4908
Myers TM, Pieters A, Moyer SA (1997) A highly conserved region of the Sendai virus nucleocapsid protein contributes to the NP-NP binding domain. Virology 229:322–335
El NF, Lampe L, Baker ML, Wang LF, Dutch RE (2015) Analysis of cathepsin and furin proteolytic enzymes involved in viral fusion protein activation in cells of the bat reservoir host. PloS One 10:e0115736
Scheid A, Choppin PW (1974) Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57:475–490
Ortmann D, Ohuchi M, Angliker H, Shaw E, Garten W, Klenk HD (1994) Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. J Virol 68:2772–2776
He B, Lin GY, Durbin JE, Durbin RK, Lamb RA (2001) The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol 75:4068–4079
Lin Y, Bright AC, Rothermel TA, He B (2003) Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J Virol 77:3371–3383
Li Z, Xu J, Patel J, Fuentes S, Lin Y, Anderson D, Sakamoto K, Wang L, He B (2010) Function of the small hydrophobic protein of J paramyxovirus. J Virol 85:32–42
Rima BK, Gatherer D, Young DF, Norsted H, Randall RE, Davison AJ (2014) Stability of the parainfluenza virus 5 genome revealed by deep sequencing of strains isolated from different hosts and following passage in cell culture. J Virol 88:3826–3836
Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A (1996) The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 225:156–162
Lamb RA, Jardetzky TS (2007) Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struc Biol 17:427–436
Connolly SA, Leser GP, Jardetzky TS, Lamb RA (2009) Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J Virol 83:10857–10868
Acknowledgments
This study was funded by grant from National Key Research and Development Program (2016YFD0501006).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Liu, C., Li, X., Zhang, J. et al. Isolation and genomic characterization of a canine parainfluenza virus type 5 strain in China. Arch Virol 162, 2337–2344 (2017). https://doi.org/10.1007/s00705-017-3387-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-017-3387-0